Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

A Rise in Plasma Coagulability during the First 3 Months Following Provoked Venous Thromboembolism Is Associated with the Development of Post-Thrombotic Syndrome in Children and Young Adults: Analysis of the Kids-DOTT Multicenter Trial-Derived Biobank

Marisol Betensky, MDMPH, Ernest Amankwah, PhD, Stephanie Brandal, Allen Everett, MD, Neil A Goldenberg, MD PhD

Blood (2019) 134 (Supplement_1): 2424.

https://doi.org/10.1182/blood-2019-131821

Published: 2019

Journal Articles

A Novel Point-of-Care Whole Blood Coagulation Assay to Monitor Emicizumab Therapy in Patients with Hemophilia

Michael A Suster, PhD, Debnath Maji, M.Tech, Lalitha V. Nayak, MD, Christina Jenkins, MSN-PNP, RN, Susan Hunter, BSN, RN-BC, Alvin H. Schmaier, MD, Pedram Mohseni, PhD, Sanjay Ahuja

Blood (2018) 132 (Supplement 1): 2475.

https://doi.org/10.1182/blood-2018-99-113623

Published: 2018

Journal Articles

Pre-Analysis for Hemostatic Effect of Bypassing Agents in Hemophilia a Patients with Inhibitors Under the Emicizumab Prophylaxis By Global Assays

Shoko Furukawa, MD, Keiji Nogami, MD PhD, Tomoko Matsumoto, PhD, Ryu Kasai, MSc, Midori Shima, MD PhD

Blood (2018) 132 (Supplement 1): 3793.

https://doi.org/10.1182/blood-2018-99-114355

Published: 2018

Journal Articles

A Modified Thrombin Generation Analysis to Measure the Plasma Coagulation Potency in the Presence of Anti-FIXa/FX Bispecific Antibody, Emicizumab

Kenichi Ogiwara, MD PhD, Keiji Nogami, MDPhD, Tomoko Matsumoto, PhD, Mariko Noguchi-Sasaki, PhD, Tetsuhiro Soeda, PhD, Naoki Matsumoto, PhD, Michinori Hirata, PhD, Midori Shima, MD PhD

Blood (2018) 132 (Supplement 1): 1200.

https://doi.org/10.1182/blood-2018-99-118504

Published: 2018

Journal Articles

A Bispecific Antibody Lacks Measurability in Routine Coagulation Assays and Comparability to Factor VIII

Rudolf Hartmann, PhD, Tjerk Feenstra, MSc, Sabine Knappe, PhD, Gerald Schrenk, PhD, Friedrich Scheiflinger, PhD, Michael Dockal, PhD

Blood (2017) 130 (Supplement 1): 1080.

https://doi.org/10.1182/blood.V130.Suppl_1.1080.1080

Published: 2017

Journal Articles

Rebound Hypercoagulability Following a Conventional Course of Anticoagulation and the Risk of Recurrent Venous Thromboembolism in Young Patients: First Analysis of the Kids-DOTT Multicenter Trial-Derived Biobank

Marisol Betensky, MDMPH, Gail Mueller, MT, Ernest Amankwah, PhD, Neil A Goldenberg, MD PhD

Blood (2017) 130 (Supplement 1): 556.

https://doi.org/10.1182/blood.V130.Suppl_1.556.556

Published: 2017

Journal Articles

Beyond Prothrombin Time and Activated Partial Thromboplastin Time: Clot Formation Rate and Clot Structure Index As Novel Parameters for Coagulation Test Running Head: Novel Parameters of Coagulation Test

Jaewoo Song, MD, Yoon Jihoon, Lee Minyong, Yoon Tae Hyun

Blood (2016) 128 (22): 4950.

https://doi.org/10.1182/blood.V128.22.4950.4950

Published: 2016

Journal Articles

A Novel Clot Waveform Analysis to Measure the Plasma Coagulation Potency in the Presence of Anti-Fixa/Fx Bispecific Antibody, Emicizumab

Keiji Nogami, MD PhD, Tomoko Matsumoto, PhD, Yuka Tabuchi, Tetsuhiro Soeda, PhD, Nobuo Arai, Takehisa Kitazawa, Hidenari Takaoka, Kunihiro Hattori, PhD, Midori Shima, MD PhD

Blood (2016) 128 (22): 1388.

https://doi.org/10.1182/blood.V128.22.1388.1388

Published: 2016

Journal Articles

Anti-Factor IXa/Factor X Antibody (ACE910) Improves the Coagulation Function in Acquired Hemophilia A ex vivo

Masahiro Takeyama, MD PhD, Keiji Nogami, MD PhD, Tomoko Matsumoto, PhD, Takehisa Kitazawa, DVM, Kunihiro Hattori, PhD, Midori Shima, MD PhD

Blood (2015) 126 (23): 3565.

https://doi.org/10.1182/blood.V126.23.3565.3565

Published: 2015

Journal Articles

Transfusion Therapy and Hydroxyurea Improves Cerebrovascular Reserve and Perfusion in Children with Sickle Cell Anemia: An MRI Study

Przemyslaw Kosinski, BSc, Paula L Croal, PhD, Suzan Williams, MD, Jackie Leung, MASc, Andrea Kassner, PhD

Blood (2015) 126 (23): 3397.

https://doi.org/10.1182/blood.V126.23.3397.3397

Published: 2015

Journal Articles

Assessing the Effect of Short and Long-Term Hydroxyurea Treatment on Cerebral Hemodynamics in Children with Sickle Cell Anemia Using Quantitative MRI: Preliminary Findings

Przemyslaw Kosinski, BSc, Paula Croal, PhD, Jackie Leung, MASc, Suzan Williams, MD, Andrea Kassner, PhD

Blood (2014) 124 (21): 4090.

https://doi.org/10.1182/blood.V124.21.4090.4090

Published: 2014

Journal Articles

An Optimal Monitoring On Bypassing Therapy for Hemophilia A Patients with Inhibitor Using aPTT-Based Clot Waveform Analysis with the Presence of Minimal TF

Junka Haku, MD, Kenichi Ogiwara, MD, PhD, Tomoko Matsumoto, PhD, Koji Yada, MD, Midori Shima, MD, PhD, Keiji Nogami, MD, PhD

Blood (2012) 120 (21): 3382.

https://doi.org/10.1182/blood.V120.21.3382.3382

Published: 2012

Journal Articles

Coagulation Functions with Clinical Phenotype and Inhibitory Mechanisms in Acquired Factor V Inhibitors.

Tomoko Matsumoto, PhD, Keiji Nogami, MD, PhD, Kenichi Ogiwara, MD, PhD, Midori Shima, MD, PhD

Blood (2012) 120 (21): 2232.

https://doi.org/10.1182/blood.V120.21.2232.2232

Published: 2012

Journal Articles

A Coagulation Mechanism for the Mild Bleeding Tendency in a Patient with Severe Hemophilia A Possessing an Arg1781His Mutation.

Koji Yada, MD, Keiji Nogami, MD, PhD, Kenichi Ogiwara, MD, PhD, Hironao Wakabayashi, MD, PhD, Philip J. Fay, PhD, Midori Shima, MD, PhD

Blood (2012) 120 (21): 2213.

https://doi.org/10.1182/blood.V120.21.2213.2213

Published: 2012

Journal Articles

Waveform Analysis Extends the Capabilities of aPTT and PT Clotting Assays for Detecting Factor Deficiency and Monitoring Procoagulant Drug Therapy

Lilley Leong, PhD, MS, Xiaoqiao Jiang, BS, Jill Cifrese, MS, John E. Murphy, PhD, Jesper Haaning, PhD, Timothy Myles, PhD

Blood (2011) 118 (21): 1205.

https://doi.org/10.1182/blood.V118.21.1205.1205

Published: 2011

Journal Articles

Assessment of Global Hypercoagulability and Fibrinolytic Potential in Pediatric VTE: Findings From A Single-Institutional Prospective Inceptional Cohort Study.

Chris Bombardier, BS, Neil A. Goldenberg, MD, PhD, Emily L. Joachim, BS, Marilyn J. Manco-Johnson, MD

Blood (2009) 114 (22): 2988.

https://doi.org/10.1182/blood.V114.22.2988.2988

Published: 2009

Journal Articles

Identification of a Factor IXa-Interactive Site within the C2 Domain of Factor VIIIa and a Crucial Role of These Associations for the Process of Clot Formation

Tetsuhiro Soeda, Keiji Nogami, Kenichi Ogiwara, Masahiro Takeyama, Katsumi Nishiya, Midori Shima

Blood (2008) 112 (11): 1035.

https://doi.org/10.1182/blood.V112.11.1035.1035

Published: 2008

Journal Articles

Evidence of Increased Plasma Coagulative Capacity by CloFAL Assay among Pediatric Factor V Leiden and Prothrombin G20210A Heterozygotes with, Versus without, a First-or Second-Degree Family History of Venous Thromboembolism

Chris Bombardier, BS, Linda J. Jacobson, MT, Marilyn J. Manco-Johnson, MD, Neil A Goldenberg, MD, PhD

Blood (2008) 112 (11): 5345.

https://doi.org/10.1182/blood.V112.11.5345.5345

Published: 2008

Journal Articles

Influence of Factor IX on Overall Plasma Coagulability and Fibrinolytic Potential in Hemophilia B as Measured by Global Assay.

Neil A. Goldenberg, MD, William E. Hathaway, M.D., Christopher Bombardier, Kelly McFarland, B.S., Linda Jacobson, M.T., Marilyn J. Manco-Johnson, M.D.

Blood (2006) 108 (11): 1034.

https://doi.org/10.1182/blood.V108.11.1034.1034

Published: 2006

Journal Articles

Biphasic Waveform of the Activated Partial Thromboplastin Time (A2 Flag) Is Associated with Adverse Events in the Coronary Care Unit.

Christopher Bane, MD, Ferdinand S. Leya, MD, Bruce E. Lewis, MD, Jeanine M. Walenga, PhD

Blood (2005) 106 (11): 4037.

https://doi.org/10.1182/blood.V106.11.4037.4037

Published: 2005

NARROW

A Rise in Plasma Coagulability during the First 3 Months Following Provoked Venous Thromboembolism Is Associated with the Development of Post-Thrombotic Syndrome in Children and Young Adults: Analysis of the Kids-DOTT Multicenter Trial-Derived Biobank

A Novel Point-of-Care Whole Blood Coagulation Assay to Monitor Emicizumab Therapy in Patients with Hemophilia

Pre-Analysis for Hemostatic Effect of Bypassing Agents in Hemophilia a Patients with Inhibitors Under the Emicizumab Prophylaxis By Global Assays

A Modified Thrombin Generation Analysis to Measure the Plasma Coagulation Potency in the Presence of Anti-FIXa/FX Bispecific Antibody, Emicizumab

A Bispecific Antibody Lacks Measurability in Routine Coagulation Assays and Comparability to Factor VIII

Rebound Hypercoagulability Following a Conventional Course of Anticoagulation and the Risk of Recurrent Venous Thromboembolism in Young Patients: First Analysis of the Kids-DOTT Multicenter Trial-Derived Biobank

Beyond Prothrombin Time and Activated Partial Thromboplastin Time: Clot Formation Rate and Clot Structure Index As Novel Parameters for Coagulation Test Running Head: Novel Parameters of Coagulation Test

A Novel Clot Waveform Analysis to Measure the Plasma Coagulation Potency in the Presence of Anti-Fixa/Fx Bispecific Antibody, Emicizumab

Anti-Factor IXa/Factor X Antibody (ACE910) Improves the Coagulation Function in Acquired Hemophilia A ex vivo

Transfusion Therapy and Hydroxyurea Improves Cerebrovascular Reserve and Perfusion in Children with Sickle Cell Anemia: An MRI Study

Assessing the Effect of Short and Long-Term Hydroxyurea Treatment on Cerebral Hemodynamics in Children with Sickle Cell Anemia Using Quantitative MRI: Preliminary Findings

An Optimal Monitoring On Bypassing Therapy for Hemophilia A Patients with Inhibitor Using aPTT-Based Clot Waveform Analysis with the Presence of Minimal TF

Coagulation Functions with Clinical Phenotype and Inhibitory Mechanisms in Acquired Factor V Inhibitors.

A Coagulation Mechanism for the Mild Bleeding Tendency in a Patient with Severe Hemophilia A Possessing an Arg1781His Mutation.

Waveform Analysis Extends the Capabilities of aPTT and PT Clotting Assays for Detecting Factor Deficiency and Monitoring Procoagulant Drug Therapy

Assessment of Global Hypercoagulability and Fibrinolytic Potential in Pediatric VTE: Findings From A Single-Institutional Prospective Inceptional Cohort Study.

Identification of a Factor IXa-Interactive Site within the C2 Domain of Factor VIIIa and a Crucial Role of These Associations for the Process of Clot Formation

Evidence of Increased Plasma Coagulative Capacity by CloFAL Assay among Pediatric Factor V Leiden and Prothrombin G20210A Heterozygotes with, Versus without, a First-or Second-Degree Family History of Venous Thromboembolism

Influence of Factor IX on Overall Plasma Coagulability and Fibrinolytic Potential in Hemophilia B as Measured by Global Assay.

Biphasic Waveform of the Activated Partial Thromboplastin Time (A2 Flag) Is Associated with Adverse Events in the Coronary Care Unit.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only